Gary Titus's Net Worth

$1.27 Million

Estimate Recalculated Sep 13, 2024 03:57PM EST

Who is Gary Titus?

Gary Titus has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include KOSAN BIOSCIENCES INC, NUVELO INC, ImmunoCellular Therapeutics, Ltd., and SCICLONE PHARMACEUTICALS INC.

SEC CIK

Gary Titus's CIK is 0001298900

Past Insider Trading and Trends

2006 was Gary Titus's most active year for acquiring shares with 13 total transactions. Gary Titus's most active month to acquire stocks was the month of July. 2012 was Gary Titus's most active year for disposing of shares, totalling 7 transactions. Gary Titus's most active month to dispose stocks was the month of May. 2011 saw Gary Titus paying a total of $1,045,991.90 for 241,838 shares, this is the most they've acquired in one year. In 2006 Gary Titus cashed out on 75,831 shares for a total of $1,520,862.15, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

KOSAN BIOSCIENCES INC No price found

Sr. VP and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-21.53K
—
—
0
Jun 26
Form 4
+5.34%
1.09K
$1.45
$1,587.22
21.53K
Mar 31
Form 4
+17.47%
3.04K
$1.31
$3,978.14
20.44K
Mar 10
Form 4
+56.06%
6.25K
$1.57
$9,812.50
17.4K
Mar 5
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Jan 2
Form 4
+28,571.43%
10K
$3.99
$39,934.68
10.04K
Oct 31
Form 4
—
0
—
—
0
Sep 5
Form 3
—
0
—
—
0
No matching records found

NUVELO INC (ABIO) Snapshot price: $2.48

Chief Acct.Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$11.65
-$253,470.00
2.63K
Aug 30
Form 4
—
0
$14.91
-$78,454.04
2.63K
Aug 29
Form 4
—
0
$14.62
-$425,402.00
2.63K
Aug 25
Form 4
—
0
$14.66
-$145,125.00
2.63K
Aug 24
Form 4
+16.91%
604
$10.47
$4,862.90
4.18K
Aug 31 - Aug 1
Form 4
∞
326
$6.45
$2,101.50
326
Feb 28 - Aug 1
Form 4
+673.25%
1.64K
$7.52
$12,310.84
1.88K
Nov 30 - Feb 23
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

ImmunoCellular Therapeutics, Ltd. (IMUC) Snapshot price: $0.0182

Chairman and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
+55.56%
10K
—
—
28K
Sep 18
Form 4
—
0
—
—
0
Jun 26
Form 4
—
0
—
—
0
Jun 13
Form 4
∞
18K
$0.78
$14,039.99
18K
Dec 20
Form 4
—
0
—
—
0
Sep 20
Form 4
—
0
—
—
0
Mar 7
Form 3
—
0
—
—
0
No matching records found

SCICLONE PHARMACEUTICALS INC No price found

Senior VP Finance & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.71%
261
$3.98
-$492,805.26
37.09K
May 31 - Jun 15
Form 4
+34.05%
9.36K
—
—
36.83K
May 14
Form 4
+2.66%
711
$3.85
$2,734.13
27.48K
Aug 31 - Mar 15
Form 4
+4.18%
1.07K
$4.65
$4,998.75
26.77K
Aug 18
Form 4
+10.57%
2.46K
$4.81
$11,818.63
25.69K
May 31 - Jun 15
Form 4
—
0
—
—
0
May 27
Form 4
+5.02%
1.11K
$2.53
$2,813.37
23.24K
Aug 31 - May 12
Form 4
+12.74%
2.5K
$3.39
$8,475.00
22.13K
May 11
Form 4
—
0
—
—
0
Mar 5
Form 4
+30.83%
4.63K
$1.74
$8,034.65
19.63K
May 22
Form 4
—
0
—
—
0
Dec 16
Form 4
∞
15K
$1.01
$15,180.00
15K
Dec 11 - Dec 12
Form 3
—
0
—
—
0
No matching records found